Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.
about
Discoidin Domain Receptors: Potential Actors and Targets in CancerStructure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors.Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.Identification of novel inhibitors of DDR1 against idiopathic pulmonary fibrosis by integrative transcriptome meta-analysis, computational and experimental screening.
P2860
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.
@en
type
label
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.
@en
prefLabel
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.
@en
P2093
P2860
P1476
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.
@en
P2093
Aman Iqbal
Anne Cleasby
Emiliano Tamanini
Gordon Saxty
Ildiko M Buck
James E H Day
Jayne E Curry
Joanne M Munck
Joseph E Coyle
Keisha Hearn
P2860
P304
P356
10.1021/ACSMEDCHEMLETT.5B00143
P577
2015-06-04T00:00:00Z